Immune checkpoint inhibitors therapies in patients with cancer and preexisting autoimmune diseases: A meta-analysis of observational studies
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference25 articles.
1. The future of immune checkpoint therapy;Sharma;Science,2015
2. Pooled analysis safety profile of nivolumab and ipilimumab combination therapy in patients with advanced melanoma;Sznol;J Clin Oncol,2017
3. Prevalence of autoimmune disease among patients with lung cancer: implications for immunotherapy treatment options;Khan;JAMA Oncol,2016
4. Clinical outcomes of patients with advanced cancer and pre-existing autoimmune diseases treated with anti-programmed Death-1 immunotherapy: a real-world transverse study;Cortellini;Oncologist,2019
5. To treat or not to treat: patient exclusion in immune oncology clinical trials due to preexisting autoimmune disease;Pantuck;Cancer,2019
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparison of efficacy discrepancy between early-phase clinical trials and phase III trials of PD-1/PD-L1 inhibitors;Journal for ImmunoTherapy of Cancer;2024-01
2. The need for renal biopsy in oncology patients on check-point inhibitors check-point inhibitors: New triggers for extracapillary glomerulonephritis extracapillary glomerulonephritis;Nefrología (English Edition);2024-01
3. Effectiveness and Safety of Immune Checkpoint Inhibitors in Cancer Patients With Autoimmune Disease: A Retrospective Cohort Study;Journal of Immunotherapy;2023-11-06
4. Safety and Efficacy of Immune Checkpoint Inhibitors in Cancer Patients and Preexisting Autoimmune Disease: A Systematic Review and Meta-Analysis in Non–Small-Cell Lung Cancer;Clinical Lung Cancer;2023-11
5. Safety and efficacy of immune checkpoint inhibitor cancer therapy in patients with preexisting type 1 diabetes mellitus;Frontiers in Endocrinology;2023-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3